Literature DB >> 8937745

Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells.

S S Anderson1, K Wu, H Nagase, W G Stettler-Stevenson, Y Kim, E C Tsilibary.   

Abstract

Human mesangial cells grown in either 5 or 25 mM glucose were cultured on type IV collagen which had been previously control-incubated or in vitro glycated. Northern blot analysis revealed that after 3-7 days in culture mesangial cells on glycated type IV collagen expressed approximately 25-200% more alpha 1 (IV), approximately 20-50% less matrix metalloproteinase 2 (MMP-2), and 65-75% more tissue inhibitor of metalloproteinase 1 (TIMP-1). Decreased immunoreactivity (approximately 30-40%) and collagenolytic activity (approximately 10-40%) corresponding to MMP-2 was also detected in media conditioned during the third day of culture on glycated type IV collagen. These effects on cell function were related to the extent of type IV collagen modification and were similar for cells cultured in 5 or 25mM glucose. Elevated glucose (25 vrs 5 mM) increased expression of alpha 1 (IV) mRNA (approximately 40-70%) and in conjunction with matrix glycation resulted in detectable levels of MMP-9 message by northern blot although collagenolytic activity corresponding to MMP-9 was not detectable by zymography. We conclude that glucose and matrix glycation may each alter mesangial cell function, perhaps leading to an imbalance in mesangial matrix synthesis and degradation which could contribute to mesangial expansion characteristic of diabetic renal disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8937745     DOI: 10.3109/15419069609010765

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  4 in total

1.  An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines.

Authors:  I Dafnis; A K Tzinia; E C Tsilibary; V I Zannis; A Chroni
Journal:  Neuroscience       Date:  2012-03-14       Impact factor: 3.590

2.  Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.

Authors:  D Cosgrove; K Rodgers; D Meehan; C Miller; K Bovard; A Gilroy; H Gardner; V Kotelianski; P Gotwals; A Amatucci; R Kalluri
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

Review 3.  Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes.

Authors:  Paul Voziyan; Kyle L Brown; Sergei Chetyrkin; Billy Hudson
Journal:  Clin Chem Lab Med       Date:  2014-01-01       Impact factor: 3.694

Review 4.  Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.

Authors:  Gaia Spinetti; Nicolle Kraenkel; Costanza Emanueli; Paolo Madeddu
Journal:  Cardiovasc Res       Date:  2008-02-15       Impact factor: 10.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.